Epilepsy in the Western Pacific Region: Call to Action

Click here to download this report. The burden of epilepsy in the Western Pacific Region of WHO is as extensive and serious as in any other region of the world. Epidemiological surveys in several countries have shown high incidence and prevalence of epilepsy, with high associated disability and high rates of serious complications, including physical injury and premature mortality. Studies have also demonstrated that most people with epilepsy do not receive appropriate treatment. The “treatment gap” in less developed countries is an estimated 70% to 95%. Safe, effective and inexpensive medication exists that can control seizures in most people with epilepsy but a range of cultural, economic and other factors can prevent them from receiving the treatment they need. In 2001, three initiatives came together, marking an unprecedented opportunity to remedy this situation in the Western Pacific Region. These were: (1) continued implementation of the Global Campaign Against Epilepsy (GCAE), launched in 1997; (2) the adoption of epilepsy as a priority in the Regional Strategy for Mental Health which was endorsed by the 52nd Regional Committee of the Western Pacific Region in Brunei Darussalam in September 2001; and (3) the inclusion of epilepsy as a priority condition in the World Health [...]

2017-02-18T11:51:04+00:00November 30th, 2011|

Epilepsy in the WHO South East Asian Region – Bridging the gap

Click here to download this report. Epilepsy affects about 1% of the population of the South-East Asia Region of WHO thus there are approximately 15 million people with epilepsy in the Region. Despite global advances in modern medicine, epilepsy continues to be surrounded by myths and misconceptions. Patients with epilepsy may be taken to faith healers rather than medical doctors, and only 10-20% of all patients with epilepsy receive appropriate treatment. People with epilepsy and their families have suffered ostracism by society and deprived of treatment, leading to frequent injuries and sometimes, death. The situation is particularly bad in rural and remote areas where almost no services for epilepsy are available. However, as we take courage from the fact that 70 to 80% of people with epilepsy can lead normal lives if properly treated, it is time to introspect as to why 80 to 90% of people with epilepsy are not being treated at all. We must find answers and take appropriate action now. In cooperation with the governments of Member Countries, SEARO hopes to launch nationwide projects in each country to reduce the treatment gap in epilepsy. To carry forward this ambitious project, SEARO recognizes that the support of multiple [...]

2017-02-18T11:51:02+00:00November 30th, 2011|

Epilepsy in the WHO – Fostering Epilepsy Care in Europe

Click here to download this report. In Europe, at least 6 million people have epilepsy, and 15 million Europeans will have one seizure at some time in their lives. Nevertheless, in some countries of Europe, epilepsy is not recognized as a brain disorder, and up to 40% of people with this condition may be untreated – the treatment gap. Epilepsy is a treatable condition and relatively cheap medication is available. Professionals who treat people with epilepsy, however, often do not have sufficient specialized knowledge of the condition, and, in some countries, antiepileptic drugs are not always available or are not affordable and diagnostic facilities are lacking or are inadequate. It has been estimated that the 6 million people with active epilepsy in Europe cost over € 20 billion per year, and despite this, very few European countries have national plans for managing the disorder. Epilepsy continues to take its toll, impairing the physical, psychological and social functioning of those affected and equally causes serious psychological, social and economic consequences for their families. People with epilepsy, and sometimes their family members, are often stigmatized, generating a hidden burden which discourages them from seeking the diagnosis and care they require. Stigma leads to [...]

2017-02-18T11:51:00+00:00November 30th, 2011|

EU Written Declaration on Epilepsy Receives Strong Support

Declaration No 22-2011 Submitted by Gay Mitchell, Nirj Deva, Marian Harkin, Peter Skinner, Angelika WerthmannThe European Union (EU) Written Declaration on Epilepsy is receiving very good support from Members of the European Parliament (MEPs) from throughout Europe. The declaration first opened for signatures during the plenary session in Strasbourg in May, when a total of 107 MEPs added their signatures to the book.During the second opportunity for signing, in early June, a further 138 MEPs signed the declaration, bringing the total to 245 signatures. On the 22nd/23rd June a short mini-session in Brussels brought a further 30 further signatures. So, at the end of June 2011, 275 MEPs have signed the declaration demonstrating their support for people with epilepsy in Europe.In order to have the EU Written Declaration on Epilepsy carried in the European Parliment, we need to receive a minimum of 369 signatures (a majority of all MEPs).Listed below are the names of the MEPs who have signed during the May and June sessions. IBE, the International League Against Epilepsy (ILAE) and the European Advocates for Epilepsy Group (which is chaired by Gay Mitchell MEP) are extremely grateful to those MEPs who have already put their names to the declaration.The [...]

2017-02-18T11:50:49+00:00June 14th, 2011|

Epilepsy and Employment: a guide for workers and employers

Epilepsy and Employment: a guide for workers and employers A guidebook on epilepsy and employment, geared at people with epilepsy and their employers, has been published in Australia by Epilepsy ACT. The publication was launched at the Australian Capital Territory’s Legislative Assembly in May 2011, with Senator Gary Humphries acting as Master of Ceremonies and Minister Joy Burch introducing the publication. The publication has been well received by Australian politicians and by people with epilepsy and their carers. Prior to publication, the document was checked by five lawyers and was also reviewed by a focus group of persons with epilepsy. While the publication will undoubtedly be of interest to people with epilepsy globally, please note that any reference to legislation refers to Australian law only and is likely to be different in other countries. We would like to thank Jacinta Cummins and her colleagues at Epilepsy ACT for sharing the document with us. Click here to download Epilepsy and the Workplace: a guide for workers and employers.

2017-02-18T11:50:37+00:00June 14th, 2011|

Two new associate members join IBE!

IBE is delighted to announce that two new members have joined the organisation. National Society for Epilepsy (United Kingdom) is a new associate member in the European Region, which brings the number of members to 35 Full Members and 18 Associate Members in this region. Epilepsy Association ACT Inc (Australia) has joined as an associate member bringing the number of Associate Members to 7 in the Western Pacific region in addition to 10 Full Members. IBE wishes these new members every success in the future.

2016-05-03T20:14:36+00:00February 22nd, 2010|

New associate member in Europe!

IBE would like to welcome our new Associatel Member in the European region: National Society for Epilepsy (United Kingdom) This brings the number of members in European region to 35 Full Members and 18 Associate Members. IBE wishes this new member every success in the future.

2016-05-03T20:14:52+00:00February 15th, 2010|

Indian Epilepsy Association Programs

The Indian Epilepsy Association, which was founded in 1971, has conducted valuable programs for the benefit of people with epilepsy. For more information about these programs, please click here.

2017-02-18T11:48:54+00:00July 21st, 2009|

Promising Strategies Program

Background The International Bureau for Epilepsy (IBE) is committed to finding new and innovative solutions to the problems impacting people with epilepsy and their families world-wide. As part of this commitment, IBE is providing a limited amount of financial support to IBE member organizations on a competitive basis for initiatives aimed at improving the quality of life for people with epilepsy in developing nations. Definition of a Promising Strategy A Promising Strategy is one that has the potential to foster effective and innovative public health practice with regard to epilepsy. Ideally, a Promising Strategy contains many of the following: Is based on measurable, realistic, and time specific objectives Is need-based and data-driven Is innovative and represents the development of new solutions to common problems impacting people with epilepsy and their families Establishes a strategy that makes a difference in improving accessibility to accurate, timely, necessary and culturally appropriate information and/or services Demonstrates a sustainable effect in the community where it is being implemented Has the potential for replication of positive results if the program is implemented in a similar environment with a similar target population as its original pilot demonstration Is a strategy that can be used to generate policies and [...]

2016-10-20T16:43:24+00:00May 28th, 2008|
Go to Top